Literature DB >> 9758355

Donor lymphocyte infusion at unstable mixed chimerism in an allogeneic BMT recipient for chronic granulomatous disease.

S Akioka1, H Itoh, I Ueda, Y Matsumoto, H Iwami, K Tsunamoto, S Hibi, S Todo, T Sawada, S Imashuku.   

Abstract

We report a 14-year-old boy who had successfully received allogeneic BMT for chronic granulomatous disease and 3 years later was treated with donor lymphocyte infusion (DLI, 3.3 x 10(8) cells/kg) at unstable mixed chimerism in association with reduced neutrophil function. Following DLI, the patient developed transient acute hepatic GVHD, which was confirmed by liver biopsy and was manageable with cyclosporin A and prednisolone. The patient eventually attained complete chimerism with improved neutrophil function. At the time of writing (2.5 years from the DLI), the patient is doing well, free from infectious episodes and chronic GVHD. Our experience suggests that DLI could be a safe and effective strategy for dissolution of unstable mixed chimerism in BMT recipients for inherited disorders.

Entities:  

Mesh:

Year:  1998        PMID: 9758355     DOI: 10.1038/sj.bmt.1701394

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection.

Authors:  Keisuke Kato; Yasuko Kojima; Chie Kobayashi; Kazumasa Mitsui; Ryoko Nakajima-Yamaguchi; Kazuko Kudo; Toshihiro Yanai; Ai Yoshimi; Tomohei Nakao; Tomohiro Morio; Mureo Kasahara; Kazutoshi Koike; Masahiro Tsuchida
Journal:  Int J Hematol       Date:  2011-10-21       Impact factor: 2.490

2.  Bone marrow aplasia following donor lymphocyte infusion in 4-year-old patient with chronic granulomatous disease after allogeneic stem cell transplantation: case report.

Authors:  Magdalena Cienkusz; Monika Lejman; Nel DĄbrowska-Leonik; Marta Choma; Katarzyna Drabko
Journal:  Cent Eur J Immunol       Date:  2020-09-24       Impact factor: 2.085

3.  An Experience of Donor Lymphocyte Infusion after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.

Authors:  Tahereh Rostami; Azadeh Kiumarsi
Journal:  Pediatr Rep       Date:  2020-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.